MYD88 and diabetes mellitus: The hallmark study of Wen and colleagues first reported that GF but not specific pathogen-free non-obese diabetic (NOD) mice devoid of MyD88, a key intracellular component of multiple Toll-like receptor-mediated signaling pathways, did develop robust diabetes, and colonization of a defined microbial consortium could mitigate diabetes (128).